Condition
mHSPC clinical trials and research
As of November 12, 2026, Find a Trial lists 2 mHSPC clinical trials that are recruiting, at sites in 2 countries (most in United Kingdom (1), China (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Lower-dose ARPI therapy for metastatic prostate cancer
This trial tests whether using half the usual dose of ARPI therapy can work as well as a full dose for men with metastatic prostate cancer who are also receiving standard hormone therapy.
-
Darolutamide with ADT and Low-Dose Docetaxel in Advanced Prostate Cancer
This trial tests whether adding a low dose of docetaxel to darolutamide plus androgen deprivation therapy helps patients with metastatic hormone-sensitive prostate cancer achieve undetectable PSA levels.
Related topics
Quick answers
How many mHSPC clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.